the ascent of sacituzumab govitecan in metastatic tnbc | aditya bardia
Published 4 years ago • 377 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
1:29
aditya bardia, md, mph, discusses the design of newly approved sacituzumab govitecan
-
3:10
ascent trial: sacituzumab govitecan for tnbc
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
2:23
dr aditya bardia discusses the advantages of sacituzumab govitecan for triple-negative breast cancer
-
7:14
ascent: sacituzumab govitecan vs treatment of physician’s choice in patients with previously tre...
-
21:46
breast part 2: malignant disease absite and board review
-
6:17
antibody-drug conjugates in tnbc: sacituzumab govitecan
-
19:01
adrenal incidentalomas – please participate in our 3-minute survey below!
-
1:47
dr. bardia on sacituzumab govitecan in tnbc
-
2:40
dr. bardia on sacituzumab govitecan in triple-negative breast cancer
-
2:15
ascent: sacituzumab govitecan biomarker analysis
-
1:58
ascent-04: sacituzumab govitecan and pembrolizumab in pd-l1-positive tnbc
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients
-
5:27
sacituzumab govitecan demonstrates metastatic urothelial cancer benefit | yohann loriot
-
2:44
dr aditya bardia forecasts what’s to come for the ascent trial in triple-negative breast cancer
-
5:08
potential of sacituzumab govitecan plus pembrolizumab demonstrated in muc patients | petros grivas
-
1:12
dr. aditya bardia on rad1901 in er-positive metastatic breast cancer
-
3:47
sacituzumab govitecan in mtnbc
-
15:06
dr. aditya bardia | san antonio breast cancer symposium 2022 | general session
-
3:59
sacituzumab govitecan for treatment-refractory metastatic breast cancer
-
10:11
the oncology brothers discuss data presented at asco 2023 on metastatic breast cancer
-
28:25
metastatic triple-negative breast cancer ongoing trials